Embree Financial Group’s TELA Bio TELA Stock Holding History

Embree Financial Group’s Portfolio TELA Stock Details TELA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$68.2K	Sell	90,906 -27,272	-23%	-$22.3K	0.01%	283
2026 Q1	$73.3K	Buy	118,178 +6,860	+6%	+$5.96K	0.01%	261
2025 Q4	$131K	Buy	111,318 +97,318	+695%	+$123K	0.02%	233
2025 Q3	$20.9K	Hold	14,000	–	–	﹤0.01%	232
2025 Q2	$27.2K	Hold	14,000	–	–	﹤0.01%	214
2025 Q1	$17.1K	Buy	14,000 +1,500	+12%	+$3.69K	﹤0.01%	201
2024 Q4	$37.8K	Buy	12,500 +2,500	+25%	+$7.03K	0.01%	194
2024 Q3	$25.3K	Buy	+10,000	New	+$35.6K	﹤0.01%	195

Other funds holding TELA

EWM

Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

USWIA

UP Strategic Wealth Investment Advisors Pittsburgh, Pennsylvania $168M AUM 30.07% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

DWP

Destiny Wealth Partners Tavares, Florida $709M AUM 19.96% 1-Year Est. Return

DWM

Ducere Wealth Management Newport Beach, California $333M AUM

TWC

TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return

PWA

Primoris Wealth Advisors North Palm Beach, Florida $219M AUM 77.87% 1-Year Est. Return

Embree Financial Group's TELA Position: Q2 2026 in Review

Embree Financial Group reduced its TELA Bio (TELA) stake by 23% in Q2 2026, selling an estimated $22.3K and leaving 90,906 shares worth $68.2K. The position accounts for 0.01% of the portfolio, ranked #283.

Embree Financial Group first reported a position in TELA in Q3 2024 and has held it in 8 quarters since. The position peaked at $131K in Q4 2025. 15 funds tracked by Wall St. Rank hold TELA as of Q2 2026.

Embree Financial Group held 90,906 shares of TELA Bio worth $68.2K as of Q2 2026.
Embree Financial Group sold 27,272 TELA Bio shares in Q2 2026, an estimated $22.3K.
TELA Bio made up 0.01% of Embree Financial Group's portfolio in Q2 2026, its #283 holding.
Embree Financial Group first reported a position in TELA Bio in Q3 2024 and has held it in 8 quarters since.
Embree Financial Group's TELA Bio position peaked at $131K in Q4 2025.
15 funds tracked by Wall St. Rank held TELA Bio as of Q2 2026.

Based on Embree Financial Group's 13F filing for Q2 2026, filed 15 Jul 2026.